Searched for
CYNDRELLA CARVALHO
CRO market still very much untapped in India: Cyndrella CarvalhoIndian CROs and CDMOs are attracting a lot of attention as companies, such as Syngene, Suven, and Divis, create long-term relationships wit...- Ipca bleeds as Street fears Unichem acquisition a likely earnings dragIpca on Monday announced the acquisition of Unichem by acquiring a 33.38% stake from the promoter at ₹1,034 crore. It will spend another ₹8...
- Pharma sector to benefit from softening of raw material inflation: Cyndrella CarvalhoThe pharmaceutical sector is set to benefit from the softening of raw material inflation, according to Cyndrella Carvalho of JM Financial, ...
- Cyndrella Carvalho on 6 pharma stocks to bet on nowValuations in the listed API space have experienced huge price corrections, making them appear attractive, according to Cyndrella Carvalho,...
- Cyndrella Carvalho's top 3 pharma picks for next 12 months“The opportunity in the Covid pill market looks significantly high. We will wait and watch in terms of how the data pans out.”
- Upgrade cycle in Sun Pharma will continue: Cyndrella Carvalho“The upgrade cycle will continue and I see a very good performance delivered. We had around Rs 1800 odd PAT estimates whereas they have del...
- Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
- There is scope to rise for some midcaps after recent fallET has compiled a list of 10 stocks on which analysts remain bullish for foreseeable future.
Load More